Peripherally Inserted Central Catheter (PICC) Line

A peripherally inserted central catheter, commonly called a PICC or PICC line, is a long, thin tube threaded into a vein in the upper arm and advanced until its tip rests near the heart, giving clinicians reliable access to the central bloodstream without the risks of a direct chest or neck insertion. PICCs are used to deliver medications that would damage smaller veins, such as chemotherapy drugs, certain antibiotics, and concentrated nutrition solutions, often for weeks or months at a time. They sit at a middle ground in the world of intravenous access: less invasive to place than a surgically implanted port, yet far more durable than a standard IV. That balance of convenience and capability has made PICCs one of the most widely used central venous devices in modern hospitals and outpatient care, though they come with a distinct set of risks and trade-offs worth understanding.

How a PICC Gets Placed

Insertion usually happens at the bedside or in a procedure room rather than an operating suite. A clinician uses ultrasound to locate a suitable vein in the upper arm, most often the basilic vein, which runs along the inner side of the bicep. The basilic vein tends to be larger and straighter than alternatives in the arm, and anatomical studies show its average diameter is roughly 4 to 5 millimeters, with the left arm generally offering a slightly wider vessel and a longer path to the heart than the right.¹ A local anesthetic numbs the insertion site, a needle accesses the vein, and the catheter is guided through the venous system until the tip sits in the lower third of the superior vena cava, just above the right atrium of the heart.

Confirming that the tip landed in the right spot is critical. The traditional method is a post-procedure chest X-ray, but many centers now use real-time electrocardiogram (ECG) guidance. As the catheter tip approaches the heart, the ECG signal changes in a predictable way, letting the clinician “watch” the tip arrive without radiation. Research in patients with atrial fibrillation, who have irregular heart rhythms that complicate the ECG reading, found that ECG-guided verification still performed well, with sensitivity above 90% for correct tip placement.² A study in brain-injury patients showed that combining ECG guidance with ultrasound raised the correct placement rate from about 79% to over 90% compared with ultrasound alone.³ That accuracy matters because a tip that drifts too far into the heart can trigger arrhythmias, while one that stops too short sits in a smaller vessel and raises the risk of clotting.

When a PICC Is the Right Choice

PICCs make the most sense for intravenous therapies expected to last more than about two weeks, especially when the medications being given are too harsh for a regular IV. Chemotherapy agents, prolonged courses of antibiotics, total parenteral nutrition, and certain concentrated electrolyte solutions all qualify. A multispecialty appropriateness panel rated PICC use as inappropriate when the expected duration was five days or fewer, and for therapies lasting six to fourteen days, shorter devices like midline catheters or ultrasound-guided peripheral IVs were preferred.⁴

The logic behind that cutoff is straightforward: every day a PICC stays in a vein is a day that blood clots and infections can develop. If the therapy is short enough that a simpler device can handle it, exposing a patient to PICC-related risks is hard to justify. On the other hand, PICCs can remain in place for months when properly maintained, which makes them ideal for outpatient antibiotic courses, ongoing cancer treatment, and home-based IV nutrition.

What PICCs Are Made Of

Most PICCs are constructed from either thermoplastic polyurethane or silicone, both of which are flexible enough to navigate the venous curves between the arm and the chest. Polyurethane lines tend to be stiffer at room temperature and soften once they reach body temperature, which helps during insertion. Silicone lines are softer from the start, which some clinicians prefer for patients who will have the line for an extended period. Both materials, however, can release small amounts of chemical substances that leach into the bloodstream or into whatever fluid is being infused, a concern that has drawn particular attention in neonatal care, where babies receive tiny volumes and even trace contaminants carry more weight.⁵

Blood Clots and the Catheter-to-Vein Ratio

The most talked-about risk with PICCs is deep vein thrombosis, a blood clot that forms in and around the catheter. A catheter sitting inside a vein acts as a physical obstruction: it slows blood flow, rubs against the vessel wall, and provides a surface where clotting proteins can accumulate. In a simulated flow model, a centrally positioned catheter reduced venous flow by as much as 93%, underscoring just how much even a small tube disrupts normal circulation.⁶

The relationship between the catheter’s outer diameter and the vein’s inner diameter, called the catheter-to-vein ratio, is one of the strongest predictors of clot formation. Multiple studies have converged on a threshold around 45%: when the catheter occupies more than 45% of the vein’s width, thrombosis risk jumps sharply. One prospective study found that patients above this cutoff were roughly 13 times more likely to develop a clot.⁷ A separate retrospective analysis confirmed that a ratio above 45% more than doubled the risk, and the effect was especially pronounced in cancer patients.⁸

Cancer itself is independently associated with PICC-related clotting. In a large cohort, about half of patients who developed a PICC-associated deep vein thrombosis had a recent cancer diagnosis, and malignancy roughly doubled the odds of clotting after accounting for other factors. Larger-gauge catheters also carried higher risk, and clots tended to appear earlier with bigger lines.⁹ The practical takeaway is that clinicians should use the smallest catheter that will deliver the needed therapy and verify by ultrasound that the chosen vein is wide enough to keep the ratio comfortably below 45%.

Thrombosis from a PICC is not always limited to the arm. The same cohort study found that about 1% of PICC patients developed a clot in a leg vein, possibly related to immobility during hospitalization. Patients in intensive care, who tend to be bedridden for extended periods, appear to be at particular risk for both upper- and lower-extremity clots.¹⁰ All of Virchow’s classic triad of clotting risk factors can converge around a PICC: the insertion damages the vessel lining, the catheter itself disrupts flow, and many PICC patients have conditions like cancer that make their blood clot more easily.¹¹

Infections

Bloodstream infections are the second major concern. Because the catheter creates a direct highway from the skin surface to the central bloodstream, bacteria can travel along the outer surface or through the hub where medications are connected. One single-center study found that bloodstream infections were the most common PICC complication, occurring at a rate of about 1.9 per 1,000 catheter-days, which translated to roughly 8% of all inserted PICCs. The most frequent culprits were gut-associated bacteria and common skin organisms.¹²

Risk factors for infection are somewhat intuitive: older age, weakened immune function, catheter movement at the insertion site, and going more than seven days between dressing changes all independently raise the odds. Having a fever before insertion was also flagged as a risk factor, which makes sense because an existing infection can seed a newly placed device.¹³ Preventing infection comes down to strict sterile technique during insertion, regular dressing changes with antiseptic, minimizing unnecessary manipulation of the catheter hub, and removing the line as soon as it is no longer needed.

Mechanical Problems

Beyond clots and infections, PICCs can develop mechanical issues. Migration is one: the catheter tip gradually shifts from its ideal position, either slipping deeper into the heart or retreating into the upper chest. Occlusion, where the line becomes blocked by blood or medication residue, can interrupt therapy and sometimes requires the catheter to be replaced. Fracture of the catheter itself is rare but documented, and a broken fragment can potentially embolize and travel through the bloodstream. During removal, the most common source of resistance is venous spasm, where the vein clamps down on the catheter, requiring slow, gentle traction rather than force.¹⁴

PICCs Versus Midline Catheters

Midline catheters look similar to PICCs at the insertion site but are shorter; they stop in the upper arm rather than reaching the central veins. Because they do not enter the central circulation, midlines avoid some of the more serious PICC complications but cannot deliver medications that require central venous access. A large study comparing the two for outpatient antibiotic therapy found that midlines had about half the rate of major complications, with roughly 0.8% experiencing a serious device problem versus about 3.4% with PICCs.¹⁵ The advantage was most striking for courses lasting two weeks or less. For longer courses, the gap narrowed. Rates of minor complications and device failure were similar between the two, suggesting that midlines offer a meaningful safety edge primarily for shorter treatments where the drug being given is compatible with peripheral veins.

PICCs Versus Implanted Ports

For patients who need vascular access over many months, particularly people receiving repeated cycles of chemotherapy, the main alternative to a PICC is an implanted port. A port is a small reservoir placed under the skin of the chest, connected to a catheter that enters a central vein. It requires a minor surgical procedure to place, has no external components between treatments, and generally lasts longer than a PICC. Meta-analyses consistently find that PICCs carry higher overall complication rates than ports, driven mainly by more frequent thrombosis and catheter-related problems.¹⁶¹⁷

Interestingly, infection rates between PICCs and ports have not always been significantly different in pooled analyses, which challenges the common assumption that the external portion of a PICC automatically means more infections.¹⁸ The real gap is in thrombosis and overall adverse events, where ports come out ahead. Ports also have longer lifespans and, over the course of extended treatment, tend to cost less despite the upfront surgical expense.¹⁹ So why do many patients still get PICCs? Because PICCs can be placed quickly without surgery, they do not require an operating room, and they are easier to remove when therapy is finished. For someone whose treatment course is measured in weeks rather than many months, a PICC often makes more practical sense even if the complication profile is slightly worse per unit of time.

PICCs in Newborns and Children

Pediatric PICC placement is a different challenge. In newborns, the available veins are tiny and the margin for error is razor thin. Neonatal PICCs may be threaded through veins in the arm, leg, or even the scalp, depending on what is accessible.²⁰ The complication profile differs from adults. Malposition, where the catheter tip ends up somewhere other than the intended target, is the most common adverse outcome in neonates, occurring in nearly half of placements in one cohort study. Bloodstream infections in that same cohort were reported at about 6%, while serious events like pleural effusion and heart rhythm disturbances were rare, each under 1%.²¹

Life-threatening complications do exist in the neonatal population, though. PICC tips that migrate into the heart can cause pericardial effusion, where fluid accumulates around the heart, leading to cardiac tamponade, a medical emergency. Pleural effusion from a misplaced or perforated catheter is another rare but dangerous scenario. These risks underscore why neonatal PICCs require especially vigilant monitoring and frequent imaging to confirm tip position.²²

Living with a PICC at Home

Many patients are discharged with a PICC still in place, and the adjustment to daily life can be surprisingly disruptive. Showering becomes a careful ritual of waterproof covers and arm positioning. Clothing choices change. Sleep gets interrupted by anxiety about rolling onto the arm or accidentally pulling the line. Exercise is limited. Parents with young children describe the added stress of protecting the site from curious toddlers. A qualitative study identified eight broad areas where home PICC patients needed support, with adapting daily activities ranking as the single greatest challenge.²³

The emotional burden is real too. Patients report anxiety about the line becoming infected, dislodged, or clotted, and many feel unprepared to manage the device despite receiving discharge instructions. Over time, however, most patients adjust. A study of cancer outpatients found that the majority eventually viewed their PICC positively and said they would recommend it to others, as they found it did not fundamentally alter their quality of life once the initial learning curve passed.²⁴ The gap between early distress and eventual acceptance highlights how much difference good patient education and accessible follow-up care can make.

Who Places It Matters

PICC insertion is increasingly performed by specially trained nurses rather than physicians, and the data supports that model. A systematic review found that dedicated vascular access specialist teams achieve higher first-attempt success rates and lower rates of catheter-related complications compared with standard practice, where PICCs are placed by whoever happens to be available.²⁵ A separate study of a nurse-led PICC service confirmed high success rates and low complication rates, with the added benefit of faster turnaround times since patients did not have to wait for a physician or interventional radiology slot.²⁶

Guided placement systems also appear to help. One cost-effectiveness analysis found that using a catheter navigation system lowered the per-placement cost because fewer lines needed to be repositioned or replaced.²⁷ When the tip lands correctly on the first try, there are no follow-up X-rays, no repeat procedures, and no delays to starting treatment.

Remote Monitoring and App-Based Care

The care transition from hospital to home is where PICCs get into trouble. Communication gaps between hospitals and post-acute facilities about dressing change schedules, flushing protocols, and when to remove the line have been documented as persistent problems. Emerging technology is trying to fill that gap. Studies of mobile app-based home care models have shown improvements in patients’ self-management ability and satisfaction, along with lower complication rates, when patients have access to structured digital guidance rather than relying on memory and paper handouts.²⁸

An internet-based multidisciplinary continuity-of-care program for cancer patients with PICCs at home found that the group receiving remote follow-up had a total complication rate of about 6%, compared with 18% in the group receiving standard care. Adherence to flushing schedules, exercise routines, and follow-up appointments all improved in the monitored group.²⁹ These are early-stage interventions, and much of the evidence comes from single-center studies in China, but the direction is consistent: keeping patients connected to clinicians after discharge reduces complications.

Cost Considerations Beyond the Device Itself

PICCs are cheap to insert relative to ports or tunneled central lines, which is part of their appeal. But the total cost of a PICC includes ongoing maintenance, dressing changes, flushing supplies, complications that require additional treatment, and sometimes replacement lines. When ports and PICCs are compared over the full arc of a long treatment course, ports often end up being less expensive despite the higher upfront cost, because they last longer and generate fewer complications.³⁰

PICCs can also generate cost savings in unexpected ways. For patients with end-stage heart failure who need frequent hospital admissions for intravenous diuretics, having a PICC in place allows those infusions to happen at home. One study found this approach significantly reduced heart-failure hospitalizations, increased the number of days patients spent out of the hospital, and lowered overall costs, even though about 40% of patients experienced some form of PICC-related complication during the follow-up period.³¹ For selected patients whose alternative is repeated emergency department visits, the trade-off makes economic and clinical sense.